Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response

Gene Therapy, Published online: 08 December 2022; doi:10.1038/s41434-022-00376-9Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response

https://www.nature.com/articles/s41434-022-00376-9

Source: Gene Therapy - December 8, 2022 Category: Genetics & Stem Cells Authors: T ábata Almeida Silva Rodrigo Barbosa Aguiar Marcelo Mori Gabriel Esquitini Machado Barbara Hamaguchi Marcelo Ferreira Marcondes Machado Jane Zveiter Moraes Source Type: research

More News: Avastin | Gene Therapy | Genetics